Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
31,523,534
-
Total 13F shares
-
1,897,106
-
Share change
-
+240,831
-
Total reported value
-
$1,212,138
-
Price per share
-
$0.6390
-
Number of holders
-
17
-
Value change
-
+$145,339
-
Number of buys
-
6
-
Number of sells
-
6
Institutional Holders of ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA) as of Q3 2024
As of 30 Sep 2024 ImmunoPrecise Antibodies Ltd. - Common Shares, no par value (IPA) had 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,897,106 shares of stock of the company.
Largest 10 holders included INGALLS & SNYDER LLC, RENAISSANCE TECHNOLOGIES LLC, BANK OF MONTREAL /CAN/, NORTHERN TRUST CORP, CIBC WORLD MARKET INC., Gradient Capital Advisors, LLC, Federation des caisses Desjardins du Quebec, GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, and Rathbones Group PLC.
This table shows 17 institutional shareholders of the security as of 30 Sep 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.